Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to…
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to…
Prescription drug costs, abortion rights, and the future of Obamacare are key issues in the upcoming presidential election between Vice…
If the Covid era marked a boom time for digital health companies, 2024 was the reckoning. In a year that…
In this article, CVS Health, UnitedHealth Group, and Cigna are requesting Federal Trade Commission Chair Lina Khan and two other…
In this article, Brian Thompson, the CEO of UnitedHealth Group’s insurance unit, was fatally shot outside the Hilton hotel in…
In this article, the New York Police Department has released two new photos of a person being sought in the…
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to…
In this article, Eli Lilly’s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro reported weaker-than-expected sales for the third…
In this article, Eli Lilly announced on Wednesday that its obesity drug Zepbound resulted in more weight loss compared to…